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Acute thrombus resolution: not common practice
Thromboembolus interventionism
• Surgical thromboembolectomy: through aortotomy.
• Rheolytic thromboembolectomy: through percutaneous aspiration.
Systemic thrombolysis - Tissue Plasminogen Activator
→ Treatment of choice in humans with ATE.
→ Counted cases in cats, but successful.
→ Marginally superior to antithrombotic therapy.
→ Survival notably increases in high-dose protocols (77.8%).
→ Cost may preclude its use.
ACUTE MANAGEMENT
- CONCLUSIONS -
FELINE AORTIC THROMBOEMBOLISM: 
PREVENTION AND NOVEL ACUTE MANAGEMENT APPROACHES
Sara Evangelista González
Final Degree Project – June 2020
BACKGROUND
• ATE is more common in cats than any other species, comprising
79-85% of their arterial thromboembolism cases.
• Survival rates are low, ranging from 14-40% when there is a
bilateral pelvic limb infarction.
• CMs account for 90% of ATE cases, especially HCM.
• 5-21% of cats with HCM suffer from ATE.
Bilateral pelvic limb infarction (60-71% of cases)




















1. Doppler echocardiography to define risk:
Moderate to severe LAD:
• LA:Ao > 1.9-2
• LA diameter > 17-20 mm
Blood flow velocities <0.20 m/s in
the LAA.
Spontaneous echocontrast (SEC) or
intracardiac thrombus
+/- Previous history of ATE
Figure: Right parasternal short-axis view of a cat with restrictive CM and severe LAD
and SEC (white arrows). LA (Left atrium); Ao (Aorta) (Chetboul et al. 2019) [Modified].
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2. Criteria for treatment application





Recommendation           Indication
3. Thromboprophylactic treatment









LAD, SEC, low blood 





• Requires further studies in cats
Reperfusion syndromeBlood flow 
resumption
Treatment must be attempted in





• Proved to reduce ATE 
recurrence and cardiac 
death.
 The detection of LAD, SEC and low blood flow velocities in the LAA can successfully predict ATE risk.
 The protocolisation of Doppler echocardiography in target patients and thromboprophylaxis prescription may significantly reduce ATE onset.
 Acute thrombus resolution techniques seem promising for cats with multiple limb infarction since they do not respond to antithrombotics.
 Early intervention of thrombus is crucial for survival, and its implementation in protocols could reduce euthanasia rates at presentation.
 Further studies are required to confirm the best multimodal thromboprophylactic therapy upon NOACs’ normalisation and to evaluate the




• Duration of ischaemia
• Extension of ischaemia
Abbreviations: ATE = aortic thromboembolism; CM = cardiomyopathy; HCM = hypertrophic
cardiomyopathy; LAD = left atrial dilation; LAA = left atrial appendage; LMWHs = low molecular
weight heparins; NOACs = new oral anticoagulants; UFHs = unfractionated heparins.
OBJECTIVES
• To perform a review on the state of the art of ATE’s acute
management and preventive approaches.





Loss of motor function
• Induction of a hypocoagulable state: UFHs
prevents further embolus growth and microcirculation thrombosis.
• Improvement of collateral blood flow: clopidogrel (75 mg)
avoids the release of vasoactive substances.
Antithrombotic therapy: current standard of care
→ Sufficient in cats with a single limb infarcted.
→ Insufficient in cats with ≥ 2 limbs infarcted.
→ Euthanasia at presentation in 25-61% of patients.
→ Same risk of reperfusion syndrome as infarction resolution.
OUTCOME: survival rates of 31-45% in cats with arterial thromboembolism. 
